{"transactions":[{"id":809421,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":52661,"kind":"person","name":"GOTTSCHALK ADRIAN","position":1,"cik":"0001828724","reported_name":"GOTTSCHALK ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-13T20:01:20.000Z","date":"2026-04-10","kind":"gift","planned":false,"acquired":true,"shares":59208,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Living Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On April 10, 2026, the Adrian H. Gottschalk 2025 Grantor Retained Annuity Trust dated April 25, 2025, of which the Reporting Person is the trustee and sole current beneficiary (the \"2025 GRAT\"), distributed 59,208 shares of the Issuer's Common Stock to the Living Trust."}],"balance_after":270912,"source":{"system":"sec-edgar","filing":"0001828724-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000182872426000005/primarydocument.xml","form_type":"4"}},{"id":809420,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":52661,"kind":"person","name":"GOTTSCHALK ADRIAN","position":1,"cik":"0001828724","reported_name":"GOTTSCHALK ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-13T20:01:20.000Z","date":"2026-04-10","kind":"gift","planned":false,"acquired":false,"shares":59208,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"2025 GRAT"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On April 10, 2026, the Adrian H. Gottschalk 2025 Grantor Retained Annuity Trust dated April 25, 2025, of which the Reporting Person is the trustee and sole current beneficiary (the \"2025 GRAT\"), distributed 59,208 shares of the Issuer's Common Stock to the Living Trust."}],"balance_after":240792,"source":{"system":"sec-edgar","filing":"0001828724-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000182872426000005/primarydocument.xml","form_type":"4"}},{"id":809419,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":52661,"kind":"person","name":"GOTTSCHALK ADRIAN","position":1,"cik":"0001828724","reported_name":"GOTTSCHALK ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-13T20:01:20.000Z","date":"2026-04-09","kind":"gift","planned":false,"acquired":true,"shares":47497,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Living Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 9, 2026, the Adrian H. Gottschalk 2023 Grantor Retained Annuity Trust dated May 26, 2023, of which the Reporting Person is the trustee and sole current beneficiary (the \"2023 GRAT\"), distributed 47,497 shares of the Issuer's Common Stock to the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee (the \"Living Trust\")."}],"balance_after":211704,"source":{"system":"sec-edgar","filing":"0001828724-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000182872426000005/primarydocument.xml","form_type":"4"}},{"id":809418,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":52661,"kind":"person","name":"GOTTSCHALK ADRIAN","position":1,"cik":"0001828724","reported_name":"GOTTSCHALK ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-13T20:01:20.000Z","date":"2026-04-09","kind":"gift","planned":false,"acquired":false,"shares":47497,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By 2023 GRAT"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 9, 2026, the Adrian H. Gottschalk 2023 Grantor Retained Annuity Trust dated May 26, 2023, of which the Reporting Person is the trustee and sole current beneficiary (the \"2023 GRAT\"), distributed 47,497 shares of the Issuer's Common Stock to the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee (the \"Living Trust\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001828724-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000182872426000005/primarydocument.xml","form_type":"4"}},{"id":915650,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":52661,"kind":"person","name":"GOTTSCHALK ADRIAN","position":1,"cik":"0001828724","reported_name":"GOTTSCHALK ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-02-06T21:01:11.000Z","date":"2026-02-05","kind":"grant","planned":false,"acquired":true,"shares":1075000,"price":5.23,"value":5622250.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the underlying shares of common stock on February 5, 2027, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter."}],"balance_after":1075000,"derivative":{"exercise_price":5.23,"expiration_date":"2036-02-04","underlying":"Common Stock","underlying_shares":1075000},"source":{"system":"sec-edgar","filing":"0001828724-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000182872426000003/primarydocument.xml","form_type":"4"}},{"id":1164733,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":52661,"kind":"person","name":"GOTTSCHALK ADRIAN","position":1,"cik":"0001828724","reported_name":"GOTTSCHALK ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-28T20:01:58.000Z","date":"2025-04-25","kind":"gift","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 25, 2025, the Adrian H. Gottschalk Living Trust dated September 8, 2009 (the \"Gottschalk Living Trust\"), of which the Reporting Person is the trustee, distributed 300,000 shares of the Issuer's Common Stock to the Adrian H. Gottschalk 2025 Grantor Retained Annuity Trust dated April 25, 2025 (the \"Gottschalk 2025 GRAT\"), of which the Reporting Person is the trustee and sole current beneficiary."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of 47,497 shares held by the Adrian H. Gottschalk 2023 Grantor Retained Annuity Trust dated May 26, 2023, 300,000 shares held by the Gottschalk 2025 GRAT, and 164,207 shares held by the Gottschalk Living Trust."}],"balance_after":511704,"source":{"system":"sec-edgar","filing":"0001562180-25-003257","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218025003257/primarydocument.xml","form_type":"4"}},{"id":1164732,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":52661,"kind":"person","name":"GOTTSCHALK ADRIAN","position":1,"cik":"0001828724","reported_name":"GOTTSCHALK ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-28T20:01:58.000Z","date":"2025-04-25","kind":"gift","planned":false,"acquired":false,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 25, 2025, the Adrian H. Gottschalk Living Trust dated September 8, 2009 (the \"Gottschalk Living Trust\"), of which the Reporting Person is the trustee, distributed 300,000 shares of the Issuer's Common Stock to the Adrian H. Gottschalk 2025 Grantor Retained Annuity Trust dated April 25, 2025 (the \"Gottschalk 2025 GRAT\"), of which the Reporting Person is the trustee and sole current beneficiary."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of 47,497 shares held by the Adrian H. Gottschalk 2023 Grantor Retained Annuity Trust dated May 26, 2023, 300,000 shares held by the Gottschalk 2025 GRAT, and 164,207 shares held by the Gottschalk Living Trust."}],"balance_after":511704,"source":{"system":"sec-edgar","filing":"0001562180-25-003257","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218025003257/primarydocument.xml","form_type":"4"}},{"id":1173792,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":52661,"kind":"person","name":"GOTTSCHALK ADRIAN","position":1,"cik":"0001828724","reported_name":"GOTTSCHALK ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-10T20:01:26.000Z","date":"2025-04-09","kind":"gift","planned":false,"acquired":true,"shares":197906,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 9, 2025, the Adrian H. Gottschalk 2023 Grantor Retained Annuity Trust dated May 26, 2023, of which the Reporting Person is the trustee and sole current beneficiary (the \"Gottschalk 2023 GRAT\"), distributed 197,906 shares of the Issuer's Common Stock to the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee (the \"Gottschalk Living Trust\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of 47,497 shares held by the Gottschalk 2023 GRAT and 464,207 shares held by the Gottschalk Living Trust."}],"balance_after":511704,"source":{"system":"sec-edgar","filing":"0001562180-25-003092","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218025003092/primarydocument.xml","form_type":"4"}},{"id":1173791,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":52661,"kind":"person","name":"GOTTSCHALK ADRIAN","position":1,"cik":"0001828724","reported_name":"GOTTSCHALK ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-10T20:01:26.000Z","date":"2025-04-09","kind":"gift","planned":false,"acquired":false,"shares":197906,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 9, 2025, the Adrian H. Gottschalk 2023 Grantor Retained Annuity Trust dated May 26, 2023, of which the Reporting Person is the trustee and sole current beneficiary (the \"Gottschalk 2023 GRAT\"), distributed 197,906 shares of the Issuer's Common Stock to the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee (the \"Gottschalk Living Trust\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of 47,497 shares held by the Gottschalk 2023 GRAT and 464,207 shares held by the Gottschalk Living Trust."}],"balance_after":511704,"source":{"system":"sec-edgar","filing":"0001562180-25-003092","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218025003092/primarydocument.xml","form_type":"4"}},{"id":1295290,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":52661,"kind":"person","name":"GOTTSCHALK ADRIAN","position":1,"cik":"0001828724","reported_name":"GOTTSCHALK ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-24T21:10:43.000Z","date":"2025-01-22","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":4.37,"value":1748000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the underlying shares of common stock on January 22, 2026, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter."}],"balance_after":400000,"derivative":{"exercise_price":4.37,"expiration_date":"2035-01-21","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001562180-25-000501","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218025000501/primarydocument.xml","form_type":"4"}},{"id":1670625,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":52661,"kind":"person","name":"GOTTSCHALK ADRIAN","position":1,"cik":"0001828724","reported_name":"GOTTSCHALK ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-25T21:05:59.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":3.06,"value":918000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the underlying shares of common stock on January 24, 2025, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter."}],"balance_after":300000,"derivative":{"exercise_price":3.06,"expiration_date":"2034-01-23","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001562180-24-000611","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218024000611/primarydocument.xml","form_type":"4"}},{"id":1801451,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":52661,"kind":"person","name":"GOTTSCHALK ADRIAN","position":1,"cik":"0001828724","reported_name":"GOTTSCHALK ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-08-18T20:03:37.000Z","date":"2023-08-17","kind":"gift","planned":false,"acquired":true,"shares":63000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 17, 2023, the Reporting Person transferred 63,000 shares of the Issuer's Common Stock to the Adrian H. Gottschalk Living Trust dated September 8, 2009. This was a bona fide gift with no payment in consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of 300,000 shares held by the Adrian H. Gottschalk 2023 Grantor Retained Annuity Trust dated May 26, 2023, of which the Reporting Person is the trustee and sole current beneficiary; 110,690 shares held by the Adrian H. Gottschalk 2021 Grantor Retained Annuity Trust dated November 29, 2021, of which the Reporting Person is the trustee and sole current beneficiary; and 101,014 shares held by the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee"}],"balance_after":511704,"source":{"system":"sec-edgar","filing":"0001562180-23-006432","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218023006432/primarydocument.xml","form_type":"4"}},{"id":1801450,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":52661,"kind":"person","name":"GOTTSCHALK ADRIAN","position":1,"cik":"0001828724","reported_name":"GOTTSCHALK ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-08-18T20:03:37.000Z","date":"2023-08-17","kind":"gift","planned":false,"acquired":false,"shares":63000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 17, 2023, the Reporting Person transferred 63,000 shares of the Issuer's Common Stock to the Adrian H. Gottschalk Living Trust dated September 8, 2009. This was a bona fide gift with no payment in consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-23-006432","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218023006432/primarydocument.xml","form_type":"4"}},{"id":1873013,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":52661,"kind":"person","name":"GOTTSCHALK ADRIAN","position":1,"cik":"0001828724","reported_name":"GOTTSCHALK ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-01T01:22:55.000Z","date":"2023-05-26","kind":"gift","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 26, 2023, 300,000 shares of the Issuer's Common Stock were transferred from the Adrian H. Gottschalk Living Trust dated September 8, 2009 to the Adrian H. Gottschalk 2023 Grantor Retained Annuity Trust dated May 26, 2023. This was a bona fide gift with no payment in consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of 300,000 shares held by the Adrian H. Gottschalk 2023 Grantor Retained Annuity Trust dated May 26, 2023, of which the Reporting Person is the trustee and sole current beneficiary, 110,690 shares held by the Adrian H. Gottschalk 2021 Grantor Retained Annuity Trust dated November 29, 2021, of which the Reporting Person is the trustee and sole current beneficiary, and 38,014 shares held by the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee."}],"balance_after":448704,"source":{"system":"sec-edgar","filing":"0001562180-23-004642","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218023004642/primarydocument.xml","form_type":"4"}},{"id":1873012,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":52661,"kind":"person","name":"GOTTSCHALK ADRIAN","position":1,"cik":"0001828724","reported_name":"GOTTSCHALK ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-01T01:22:55.000Z","date":"2023-05-26","kind":"gift","planned":false,"acquired":false,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 26, 2023, 300,000 shares of the Issuer's Common Stock were transferred from the Adrian H. Gottschalk Living Trust dated September 8, 2009 to the Adrian H. Gottschalk 2023 Grantor Retained Annuity Trust dated May 26, 2023. This was a bona fide gift with no payment in consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of 300,000 shares held by the Adrian H. Gottschalk 2023 Grantor Retained Annuity Trust dated May 26, 2023, of which the Reporting Person is the trustee and sole current beneficiary, 110,690 shares held by the Adrian H. Gottschalk 2021 Grantor Retained Annuity Trust dated November 29, 2021, of which the Reporting Person is the trustee and sole current beneficiary, and 38,014 shares held by the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee."}],"balance_after":448704,"source":{"system":"sec-edgar","filing":"0001562180-23-004642","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218023004642/primarydocument.xml","form_type":"4"}},{"id":1998406,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":52661,"kind":"person","name":"GOTTSCHALK ADRIAN","position":1,"cik":"0001828724","reported_name":"GOTTSCHALK ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-22T21:23:01.000Z","date":"2023-02-17","kind":"other","acquired":true,"shares":184939,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Transfer of assets between the the Adrian H. Gottschalk 2021 Grantor Retained Annuity Trust dated November 29, 2021, and the Adrian H. Gottschalk Living Trust dated September 8, 2009."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Consists of 110,690 shares held by the Adrian H. Gottschalk 2021 Grantor Retained Annuity Trust dated November 29, 2021, of which the Reporting Person is the trustee and sole current beneficiary, and 338,014 shares held by the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee."}],"balance_after":448704,"source":{"system":"sec-edgar","filing":"0001562180-23-001675","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218023001675/primarydocument.xml","form_type":"4"}},{"id":1998405,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":52661,"kind":"person","name":"GOTTSCHALK ADRIAN","position":1,"cik":"0001828724","reported_name":"GOTTSCHALK ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-22T21:23:01.000Z","date":"2023-02-17","kind":"other","acquired":false,"shares":184939,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Transfer of assets between the the Adrian H. Gottschalk 2021 Grantor Retained Annuity Trust dated November 29, 2021, and the Adrian H. Gottschalk Living Trust dated September 8, 2009."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Consists of 110,690 shares held by the Adrian H. Gottschalk 2021 Grantor Retained Annuity Trust dated November 29, 2021, of which the Reporting Person is the trustee and sole current beneficiary, and 338,014 shares held by the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee."}],"balance_after":448704,"source":{"system":"sec-edgar","filing":"0001562180-23-001675","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218023001675/primarydocument.xml","form_type":"4"}},{"id":1998404,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":52661,"kind":"person","name":"GOTTSCHALK ADRIAN","position":1,"cik":"0001828724","reported_name":"GOTTSCHALK ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-22T21:23:01.000Z","date":"2023-02-17","kind":"gift","acquired":true,"shares":4371,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"On February 17, 2023, the Reporting Person transferred 4,371 shares of the Issuer's Common Stock to the Adrian H. Gottschalk Living Trust dated September 8, 2009. This was a bona fide gift with no payment in consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Consists of 295,629 shares held by the Adrian H. Gottschalk 2021 Grantor Retained Annuity Trust dated November 29, 2021, of which the Reporting Person is the trustee and sole current beneficiary, and 153,075 shares held by the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee."}],"balance_after":448704,"source":{"system":"sec-edgar","filing":"0001562180-23-001675","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218023001675/primarydocument.xml","form_type":"4"}},{"id":1998403,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":52661,"kind":"person","name":"GOTTSCHALK ADRIAN","position":1,"cik":"0001828724","reported_name":"GOTTSCHALK ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-22T21:23:01.000Z","date":"2023-02-17","kind":"gift","acquired":false,"shares":4371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"On February 17, 2023, the Reporting Person transferred 4,371 shares of the Issuer's Common Stock to the Adrian H. Gottschalk Living Trust dated September 8, 2009. This was a bona fide gift with no payment in consideration."}],"balance_after":63000,"source":{"system":"sec-edgar","filing":"0001562180-23-001675","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218023001675/primarydocument.xml","form_type":"4"}},{"id":1998402,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":52661,"kind":"person","name":"GOTTSCHALK ADRIAN","position":1,"cik":"0001828724","reported_name":"GOTTSCHALK ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-22T21:23:01.000Z","date":"2022-10-25","kind":"other","acquired":false,"shares":4371,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Reported late due to administrative error."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Transfer of assets between the Adrian H. Gottschalk 2021 Grantor Retained Annuity Trust dated November 29, 2021, and the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Consists of 295,629 shares held by the Adrian H. Gottschalk 2021 Grantor Retained Annuity Trust dated November 29, 2021, of which the Reporting Person is the trustee and sole current beneficiary, and 148,704 shares held by the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee."}],"balance_after":444333,"source":{"system":"sec-edgar","filing":"0001562180-23-001675","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218023001675/primarydocument.xml","form_type":"4"}},{"id":1998401,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":52661,"kind":"person","name":"GOTTSCHALK ADRIAN","position":1,"cik":"0001828724","reported_name":"GOTTSCHALK ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-22T21:23:01.000Z","date":"2022-10-25","kind":"other","acquired":true,"shares":4371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Reported late due to administrative error."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Transfer of assets between the Adrian H. Gottschalk 2021 Grantor Retained Annuity Trust dated November 29, 2021, and the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"The reported holdings include 40,000 shares of the Issuer's Common Stock acquired by the Reporting Person through an option exercise reported on Form 4 on September 19, 2022."}],"balance_after":67371,"source":{"system":"sec-edgar","filing":"0001562180-23-001675","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218023001675/primarydocument.xml","form_type":"4"}},{"id":1998400,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":52661,"kind":"person","name":"GOTTSCHALK ADRIAN","position":1,"cik":"0001828724","reported_name":"GOTTSCHALK ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-22T21:23:01.000Z","date":"2022-02-10","kind":"gift","acquired":true,"shares":123479,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Reported late due to administrative error."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On February 10, 2022, the Reporting Person transferred 123,479 shares of the Issuer's Common Stock to the Adrian H. Gottschalk Living Trust dated September 8, 2009. This was a bona fide gift with no payment in consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Consists of 300,000 shares held by the Adrian H. Gottschalk 2021 Grantor Retained Annuity Trust dated November 29, 2021, of which the Reporting Person is the trustee and sole current beneficiary, and 148,704 shares held by the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee."}],"balance_after":448704,"source":{"system":"sec-edgar","filing":"0001562180-23-001675","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218023001675/primarydocument.xml","form_type":"4"}},{"id":1998399,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":52661,"kind":"person","name":"GOTTSCHALK ADRIAN","position":1,"cik":"0001828724","reported_name":"GOTTSCHALK ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-22T21:23:01.000Z","date":"2022-02-10","kind":"gift","acquired":false,"shares":123479,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Reported late due to administrative error."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On February 10, 2022, the Reporting Person transferred 123,479 shares of the Issuer's Common Stock to the Adrian H. Gottschalk Living Trust dated September 8, 2009. This was a bona fide gift with no payment in consideration."}],"balance_after":23000,"source":{"system":"sec-edgar","filing":"0001562180-23-001675","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218023001675/primarydocument.xml","form_type":"4"}},{"id":2041759,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":52661,"kind":"person","name":"GOTTSCHALK ADRIAN","position":1,"cik":"0001828724","reported_name":"GOTTSCHALK ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-30T22:02:30.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":280000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the underlying shares of common stock on January 26, 2024, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter."}],"balance_after":280000,"derivative":{"exercise_price":8.38,"expiration_date":"2033-01-25","underlying":"Common Stock","underlying_shares":280000},"source":{"system":"sec-edgar","filing":"0001562180-23-000723","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218023000723/primarydocument.xml","form_type":"4"}},{"id":2154724,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":52661,"kind":"person","name":"GOTTSCHALK ADRIAN","position":1,"cik":"0001828724","reported_name":"GOTTSCHALK ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-09-19T20:06:37.000Z","date":"2022-09-16","kind":"exercise","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested as to 25% of the underlying shares of common stock on May 30, 2018, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter until the option was fully vested."}],"balance_after":418925,"derivative":{"exercise_price":0.54,"expiration_date":"2027-05-29","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001562180-22-006726","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218022006726/primarydocument.xml","form_type":"4"}},{"id":2154723,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":52661,"kind":"person","name":"GOTTSCHALK ADRIAN","position":1,"cik":"0001828724","reported_name":"GOTTSCHALK ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-09-19T20:06:37.000Z","date":"2022-09-16","kind":"exercise","acquired":true,"shares":40000,"price":0.54,"value":21600.0,"ownership":{"direct":true},"balance_after":186479,"source":{"system":"sec-edgar","filing":"0001562180-22-006726","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218022006726/primarydocument.xml","form_type":"4"}},{"id":2422109,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":52661,"kind":"person","name":"GOTTSCHALK ADRIAN","position":1,"cik":"0001828724","reported_name":"GOTTSCHALK ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-28T21:26:40.000Z","date":"2022-01-26","kind":"grant","acquired":true,"shares":440000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested as to 25% of the underlying shares of common stock on January 26, 2023, the first anniversary of the of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested."}],"balance_after":440000,"derivative":{"exercise_price":14.87,"expiration_date":"2032-01-25","underlying":"Common Stock","underlying_shares":440000},"source":{"system":"sec-edgar","filing":"0001562180-22-000747","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218022000747/primarydocument.xml","form_type":"4"}},{"id":2593201,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":52661,"kind":"person","name":"GOTTSCHALK ADRIAN","position":1,"cik":"0001828724","reported_name":"GOTTSCHALK ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2021-08-23T21:01:35.000Z","date":"2021-08-20","kind":"exercise","acquired":false,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested as to 25% of the underlying shares of common stock on May 30, 2018, the first anniversary of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested."}],"balance_after":458925,"derivative":{"exercise_price":0.54,"expiration_date":"2027-05-29","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001562180-21-005521","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218021005521/primarydocument.xml","form_type":"4"}},{"id":2593200,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":52661,"kind":"person","name":"GOTTSCHALK ADRIAN","position":1,"cik":"0001828724","reported_name":"GOTTSCHALK ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-08-23T21:01:35.000Z","date":"2021-08-20","kind":"exercise","acquired":true,"shares":23000,"price":0.54,"value":12420.0,"ownership":{"direct":true},"balance_after":446479,"source":{"system":"sec-edgar","filing":"0001562180-21-005521","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218021005521/primarydocument.xml","form_type":"4"}},{"id":2888174,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":52661,"kind":"person","name":"GOTTSCHALK ADRIAN","position":1,"cik":"0001828724","reported_name":"GOTTSCHALK ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-02T02:23:17.000Z","date":"2021-01-28","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest as to 25% of the underlying shares of common stock on January 28, 2022, the first anniversary of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested."}],"balance_after":300000,"derivative":{"exercise_price":16.63,"expiration_date":"2031-01-27","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000899243-21-003963","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000089924321003963/doc4.xml","form_type":"4"}},{"id":2997894,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":52661,"kind":"person","name":"GOTTSCHALK ADRIAN","position":1,"cik":"0001828724","reported_name":"GOTTSCHALK ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Series B Convertible Preferred Stock","published_at":"2020-10-29T20:59:01.000Z","date":"2020-10-27","kind":"exercise","acquired":false,"shares":7207,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A-2 Convertible Preferred Stock, and Series B Convertible Preferred Stock (collectively, the \"Preferred Stock\") is convertible into the number of shares of the Registrant's common stock shown in Table II column 7 and has no expiration date. The Preferred Stock automatically converted into common stock upon the closing of the Registrant's initial public offering, which occurred on October 27, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A-2 Convertible Preferred Stock, and Series B Convertible Preferred Stock (collectively, the \"Preferred Stock\") is convertible into the number of shares of the Registrant's common stock shown in Table II column 7 and has no expiration date. The Preferred Stock automatically converted into common stock upon the closing of the Registrant's initial public offering, which occurred on October 27, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A-2 Convertible Preferred Stock, and Series B Convertible Preferred Stock (collectively, the \"Preferred Stock\") is convertible into the number of shares of the Registrant's common stock shown in Table II column 7 and has no expiration date. The Preferred Stock automatically converted into common stock upon the closing of the Registrant's initial public offering, which occurred on October 27, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A-2 Convertible Preferred Stock, and Series B Convertible Preferred Stock (collectively, the \"Preferred Stock\") is convertible into the number of shares of the Registrant's common stock shown in Table II column 7 and has no expiration date. The Preferred Stock automatically converted into common stock upon the closing of the Registrant's initial public offering, which occurred on October 27, 2020."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7207},"source":{"system":"sec-edgar","filing":"0000899243-20-029694","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000089924320029694/doc4.xml","form_type":"4"}},{"id":2997893,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":52661,"kind":"person","name":"GOTTSCHALK ADRIAN","position":1,"cik":"0001828724","reported_name":"GOTTSCHALK ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Series A-2 Convertible Preferred Stock","published_at":"2020-10-29T20:59:01.000Z","date":"2020-10-27","kind":"exercise","acquired":false,"shares":18018,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A-2 Convertible Preferred Stock, and Series B Convertible Preferred Stock (collectively, the \"Preferred Stock\") is convertible into the number of shares of the Registrant's common stock shown in Table II column 7 and has no expiration date. The Preferred Stock automatically converted into common stock upon the closing of the Registrant's initial public offering, which occurred on October 27, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A-2 Convertible Preferred Stock, and Series B Convertible Preferred Stock (collectively, the \"Preferred Stock\") is convertible into the number of shares of the Registrant's common stock shown in Table II column 7 and has no expiration date. The Preferred Stock automatically converted into common stock upon the closing of the Registrant's initial public offering, which occurred on October 27, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A-2 Convertible Preferred Stock, and Series B Convertible Preferred Stock (collectively, the \"Preferred Stock\") is convertible into the number of shares of the Registrant's common stock shown in Table II column 7 and has no expiration date. The Preferred Stock automatically converted into common stock upon the closing of the Registrant's initial public offering, which occurred on October 27, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A-2 Convertible Preferred Stock, and Series B Convertible Preferred Stock (collectively, the \"Preferred Stock\") is convertible into the number of shares of the Registrant's common stock shown in Table II column 7 and has no expiration date. The Preferred Stock automatically converted into common stock upon the closing of the Registrant's initial public offering, which occurred on October 27, 2020."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":18018},"source":{"system":"sec-edgar","filing":"0000899243-20-029694","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000089924320029694/doc4.xml","form_type":"4"}},{"id":2997892,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":52661,"kind":"person","name":"GOTTSCHALK ADRIAN","position":1,"cik":"0001828724","reported_name":"GOTTSCHALK ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-10-29T20:59:01.000Z","date":"2020-10-27","kind":"exercise","acquired":true,"shares":25225,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A-2 Convertible Preferred Stock, and Series B Convertible Preferred Stock (collectively, the \"Preferred Stock\") is convertible into the number of shares of the Registrant's common stock shown in Table II column 7 and has no expiration date. The Preferred Stock automatically converted into common stock upon the closing of the Registrant's initial public offering, which occurred on October 27, 2020."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee."}],"balance_after":25225,"source":{"system":"sec-edgar","filing":"0000899243-20-029694","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000089924320029694/doc4.xml","form_type":"4"}}]}